References
Ince TA, Cancer Cell. 2007 Aug;12(2):160-70. doi: 10.1016/j.ccr.2007.06.013. PubMed: 17692807
Caslini, Corrado et al. HDAC7 regulates histone 3 lysine 27 acetylation and transcriptional activity at super-enhancer-associated genes in breast cancer stem cells. Oncogene vol. 38,39 (2019): 6599-6614. doi:10.1038/s41388-019-0897-0, PubMed: 31375747
Fields, Evan et al. Predictive bioinformatics identifies novel regulators of proliferation in a cancer stem cell model. Stem cell research vol. 26 (2018): 1-7. doi:10.1016/j.scr.2017.11.009, PubMed: 29179130
O'Day, Elizabeth M et al. Cytidine monophosphate N-acetylneuraminic acid synthetase enhances invasion of human triple-negative breast cancer cells. OncoTargets and therapy vol. 11 6827-6838. 11 Oct. 2018, doi:10.2147/OTT.S177639, PubMed: 30349315
Chan, Stefanie et al. Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival. Molecular cancer therapeutics vol. 16,12 (2017): 2849-2861. doi:10.1158/1535-7163.MCT-17-0461, PubMed: 28878028
Marsh, Timothy et al. Hematopoietic Age at Onset of Triple-Negative Breast Cancer Dictates Disease Aggressiveness and Progression. Cancer research vol. 76,10 (2016): 2932-43. doi:10.1158/0008-5472.CAN-15-3332, PubMed: 27197230
Le, Minh T N et al. miR-200-containing extracellular vesicles promote breast cancer cell metastasis. The Journal of clinical investigation vol. 124,12 (2014): 5109-28. doi:10.1172/JCI75695, PubMed: 25401471
Sauder, Candice A M et al. Phenotypic plasticity in normal breast derived epithelial cells. BMC cell biology vol. 15 20. 10 Jun. 2014, doi:10.1186/1471-2121-15-20 PubMed: 24915897
Petrocca, Fabio et al. A genome-wide siRNA screen identifies proteasome addiction as a vulnerability of basal-like triple-negative breast cancer cells. Cancer cell vol. 24,2 (2013): 182-96. doi:10.1016/j.ccr.2013.07.008, PubMed: 23948298
Godar, Samuel et al. Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression. Cell vol. 134,1 (2008): 62-73. doi:10.1016/j.cell.2008.06.006. PubMed: 18614011
McAllister, Sandra S et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell vol. 133,6 (2008): 994-1005. doi:10.1016/j.cell.2008.04.045, PubMed: 18555776
Mendillo, Marc L et al. HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers. Cell vol. 150,3 (2012): 549-62. doi:10.1016/j.cell.2012.06.031, PubMed: 22863008